
Jeffrey Strich
@jeffreystrichmd
Lasker Clinical Research Scholar
National Heart Lung and Blood Institute
Critical Care and Infectious Disease Physician Studying Sepsis
Views are my own
ID: 1250175285233762304
14-04-2020 21:33:15
100 Tweet
304 Takipçi
163 Takip Edilen



Thank you Annals of Int Med for showcasing our study on #COVID19 surges and mortality risk in their list of most influential articles of 2021: ow.ly/ftPB50FpqTb NIH Critical Care Medicine NIH Clinical Center HHS ASPR @sarahrenee314 Vineet Chopra

Please Share! CienciaPR @blakewarner0 Jeffrey Strich @YogenKanthi Wilfredo F. Garcia-Beltran, MD, PhD David Kleiner @NIGMS NIH Clinical Center @NIAIDCareers

I am happy to share our paper on the cellular immune response of vaccinated patients with SARS-CoV-2 breakthrough infections. Thanks to the COVID-ARC Team Group at NIH led by Dr. Anthony Suffredini! academic.oup.com/jid/advance-ar… ATS Early Career NIH Critical Care Medicine NIH NHLBI NIH CC MedEd


Excellent presentation on long COVID with lots of BAL data from Dr. Anthony Suffredini's research lab and the COVID-ARC 19 Group! Julio Huapaya, @ShreyaKanth, and Jeffrey Strich


CCMD faculty Jeffrey Strich shared his research findings on the use of fostamatinib in COVID-19 and its potential use targeting neutrophils in Critical Illness


🆕️⚡️⚡️Retrospective cohort 161 US hospitals Jeffrey Strich Alexander Lawandi Sameer Kadri Association between pip/tazo MIC & survival among hospitalized pts with Enterobacterales infections MIC of ≥32/4 mg/L is associated with increased mortality academic.oup.com/jacamr/article…




Jeffrey Strich Christina Yek Morgan Walker Maniraj Neupane Alexander Lawandi Ahmed Babiker أحمد بابكر CARB-X Kevin Outterson John H. Rex, MD Global Antibiotic R&D Partnership (GARDP) AMR IndustryAlliance Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 ReAct - Action on Antibiotic Resistance #AMR #idtwitter IDSA Also nice covering piece in Stat News by ed silverman : statnews.com/pharmalot/2024…


Check out our new manuscript evaluating the impact of R406 on LPS induced neutrophil activation. R406 can inhibit NETosis, ROS, and other end-effector functions of neutrophils that can be detrimental during sepsis! @TheBethesdaLabs NIH Critical Care Medicine doi.org/10.1016/j.cell…

I am excited to share that I am starting my lab in NHLBI as a Lasker Clinical Research Scholar with the goal of understanding the pathogenesis and developing therapeutics for patients with infections that cause critical illness. NIH Critical Care Medicine @TheBethesdaLabs @Raquel_DaCruz